Targeted Strategies for Today's Evolving Markets

MissionIR Blog

NeoStem, Inc. (NBS) Starts Presentation at the Inaugural Marcum MicroCap Conference

NeoStem (AMEX:NBS) is a biopharmaceutical company engaged in the development and manufacture of cellular therapies for oncology, immunology, and regenerative medicines in the United States and China. It provides adult stem cell collection, processing, and storage services that enable healthy individuals to donate and store their stem cells for personal therapeutic use. The company also focuses on developing a pipeline of regenerative medicine therapies, which are focused on orthopedic conditions; and developing wellness, cosmetic, and anti-aging applications. For more information visit the company’s Web site at www.neostem.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below:

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *